The landscape of risk: examining the correlates of inequitable COVID-19 infection and vaccination rates in Manitoba using population-based laboratory and administrative healthcare data

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:0 publications

Grant number: 202109EG2

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2021
    2022
  • Known Financial Commitments (USD)

    $189,554.18
  • Funder

    Canadian Institutes of Health Research (CIHR)
  • Principal Investigator

    N/A

  • Research Location

    Canada
  • Lead Research Institution

    University of Manitoba
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Disabled persons

  • Occupations of Interest

    Unspecified

Abstract

COVID-19 has disproportionately impacted the most vulnerable segments of our society, those with chronic conditions, those impacted by substance use, those with intellectual disabilities, and those at sexually transmitted and bloodborne infections. This study will use population-based COVID-19 testing data linked to other sources of routinely collected data, like doctor visits, hospitalizations, and prescription drug fills to understand how things like age, where you live, and the characteristics of your neighbourhood contribute your risk of getting COVID-19 if you belonged to one of these groups. We will also examine vaccination rates within these groups, and also examine some factors that might be associated with vaccination. We will also plan on looking at factors that might be associated with people getting COVID-19 even after vaccination. The results from our study will be used to help prioritize care, including future vaccination efforts in those that have the most trouble accessing vaccines.